Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure item as well as the Revision: v3.3.2 note were removed. These changes are metadata updates and do not affect the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:58:29.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision in the page history shows the site version updated from v3.2.0 to v3.3.2, a minor update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:44:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner from the page; the rest of the study record remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:28:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The latest history entry shows a routine update to the study status and contacts; no changes to core study content or reported outcomes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T09:53:36.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Core status messaging updated to reflect funding-related operational details and a version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    7%
    Check dated 2025-10-05T14:32:38.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T09:52:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.